• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种免疫蛋白质组学方法,用于鉴定可用于诊断内脏利什曼病和人类免疫缺陷病毒合并感染的蛋白质。

An immunoproteomics approach to identify proteins to be applied for the diagnosis of visceral leishmaniasis and human immunodeficiency virus co-infection.

机构信息

Programa de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Departamento de Fisiologia e Farmacodinâmica, Laboratório de Toxicologia, FIOCRUZ, Rio de Janeiro, Rio de Janeiro, Brazil.

出版信息

Parasitology. 2020 Aug;147(9):932-939. doi: 10.1017/S0031182020000578. Epub 2020 Apr 20.

DOI:10.1017/S0031182020000578
PMID:32308186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10317630/
Abstract

The co-infection between visceral leishmaniasis (VL) and human immunodeficiency virus (HIV) has increased in several countries in the world. The current serological tests are not suitable since they present low sensitivity to detect the most of VL/HIV cases, and a more precise diagnosis should be performed. In this context, in the present study, an immunoproteomics approach was performed using Leishmania infantum antigenic extracts and VL, HIV and VL/HIV patients sera, besides healthy subjects samples; aiming to identify antigenic markers for these clinical conditions. Results showed that 43 spots were recognized by antibodies in VL and VL/HIV sera, and 26 proteins were identified by mass spectrometry. Between them, β-tubulin was expressed, purified and tested in ELISA experiments as a proof of concept for validation of our immunoproteomics findings and results showed high sensitivity and specificity values to detect VL and VL/HIV patients. In conclusion, the identified proteins in the present work could be considered as candidates for future studies aiming to improvement of the diagnosis of VL and VL/HIV co-infection.

摘要

内脏利什曼病(VL)和人类免疫缺陷病毒(HIV)的合并感染在世界上的几个国家有所增加。目前的血清学检测并不适用,因为它们对大多数 VL/HIV 病例的检测灵敏度较低,需要进行更精确的诊断。在这种情况下,本研究采用利什曼原虫抗原提取物和 VL、HIV 和 VL/HIV 患者血清以及健康受试者样本进行免疫蛋白质组学研究,旨在鉴定这些临床情况的抗原标志物。结果表明,VL 和 VL/HIV 血清中的抗体识别出 43 个斑点,通过质谱鉴定出 26 种蛋白质。其中,β-微管蛋白被表达、纯化,并在 ELISA 实验中进行了测试,作为验证我们免疫蛋白质组学研究结果的概念验证,结果显示出对检测 VL 和 VL/HIV 患者的高灵敏度和特异性。总之,本工作中鉴定的蛋白质可被视为未来研究的候选者,旨在提高 VL 和 VL/HIV 合并感染的诊断。

相似文献

1
An immunoproteomics approach to identify proteins to be applied for the diagnosis of visceral leishmaniasis and human immunodeficiency virus co-infection.一种免疫蛋白质组学方法,用于鉴定可用于诊断内脏利什曼病和人类免疫缺陷病毒合并感染的蛋白质。
Parasitology. 2020 Aug;147(9):932-939. doi: 10.1017/S0031182020000578. Epub 2020 Apr 20.
2
Assessment of a recombinant protein from Leishmania infantum as a novel tool for Visceral Leishmaniasis (VL) diagnosis in VL/HIV co-infection cases.评估利什曼原虫重组蛋白作为一种新工具在利什曼病(VL)/艾滋病毒合并感染病例中用于内脏利什曼病(VL)诊断。
PLoS One. 2021 May 17;16(5):e0251861. doi: 10.1371/journal.pone.0251861. eCollection 2021.
3
Screening diagnostic candidates from proteins for human visceral leishmaniasis using an immunoproteomics approach.利用免疫蛋白质组学方法从蛋白质中筛选人内脏利什曼病的诊断候选物。
Parasitology. 2019 Sep;146(11):1467-1476. doi: 10.1017/S0031182019000714. Epub 2019 Jun 13.
4
Identification of immunodominant proteins of Leishmania infantum by immunoproteomics to evaluate a recombinant multi-epitope designed antigen for serodiagnosis of human visceral leishmaniasis.应用免疫蛋白质组学鉴定利什曼原虫免疫优势蛋白,评估一种重组多表位设计抗原用于人内脏利什曼病的血清学诊断。
Exp Parasitol. 2021 Mar;222:108065. doi: 10.1016/j.exppara.2021.108065. Epub 2021 Jan 9.
5
High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran.伊朗南部法尔斯省内脏利什曼病流行地区的HIV感染患者中亚临床利什曼原虫感染的高发生率。
Parasitol Res. 2018 Aug;117(8):2591-2595. doi: 10.1007/s00436-018-5949-9. Epub 2018 Jun 2.
6
ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection.ChimLeish,一种新的重组嵌合蛋白,作为内脏利什曼病和人类免疫缺陷病毒合并感染的诊断和预后标志物进行评估。
Parasitol Res. 2021 Dec;120(12):4037-4047. doi: 10.1007/s00436-021-07342-1. Epub 2021 Oct 19.
7
Potential of recombinant LiHyQ, a novel Leishmania infantum protein, for the diagnosis of canine visceral leishmaniasis and as a diagnostic and prognostic marker for human leishmaniasis and human immunodeficiency virus co-infection: A preliminary study.重组 LiHyQ(一种新型利什曼原虫蛋白)在犬内脏利什曼病诊断中的潜力,以及作为人类利什曼病和人类免疫缺陷病毒合并感染的诊断和预后标志物的初步研究。
Acta Trop. 2021 Dec;224:106126. doi: 10.1016/j.actatropica.2021.106126. Epub 2021 Sep 16.
8
Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis.评价利什曼原虫吡哆醛激酶蛋白在人及犬内脏利什曼病诊断中的应用。
Immunol Lett. 2020 Apr;220:11-20. doi: 10.1016/j.imlet.2020.01.005. Epub 2020 Jan 22.
9
A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease.一种新的利什曼原虫假设蛋白可用于准确诊断犬和人内脏利什曼病,并可作为人类疾病的潜在预后标志物。
Exp Parasitol. 2020 Sep;216:107941. doi: 10.1016/j.exppara.2020.107941. Epub 2020 Jul 2.
10
Development of a Multiplexed Assay for Detection of and Protein Biomarkers in Urine Samples of Patients with Visceral Leishmaniasis.开发一种多重分析检测试剂盒,用于检测内脏利什曼病患者尿液样本中的 和 蛋白生物标志物。
J Clin Microbiol. 2019 Apr 26;57(5). doi: 10.1128/JCM.02076-18. Print 2019 May.

引用本文的文献

1
Indirect ELISA developed to detect antibodies against Mycoplasma synoviae P50 protein via immunoproteomic screening.通过免疫蛋白质组学筛选开发的间接酶联免疫吸附测定法,用于检测针对滑液支原体P50蛋白的抗体。
Appl Microbiol Biotechnol. 2025 May 6;109(1):110. doi: 10.1007/s00253-025-13503-4.
2
Immunoproteomics and phage display in the context of leishmaniasis complexity.免疫蛋白质组学和噬菌体展示在利什曼病复杂性方面的应用。
Front Immunol. 2023 Feb 8;14:1112894. doi: 10.3389/fimmu.2023.1112894. eCollection 2023.
3
Lethality among individuals infected with visceral leishmaniasis in Brazil: a retrospective study (2007-2018).巴西内脏利什曼病感染者的死亡率:一项回顾性研究(2007-2018 年)。
Parasitol Res. 2022 Feb;121(2):725-736. doi: 10.1007/s00436-022-07429-3. Epub 2022 Jan 11.
4
In Silico Design of Recombinant Chimera T Cell Peptide Epitope Vaccines for Visceral Leishmaniasis.体内利什曼病重组嵌合 T 细胞肽表位疫苗的计算机设计。
Methods Mol Biol. 2022;2410:463-480. doi: 10.1007/978-1-0716-1884-4_24.
5
Improved Performance of ELISA and Immunochromatographic Tests Using a New Chimeric A2-Based Protein for Human Visceral Leishmaniasis Diagnosis.新型基于 A2 嵌合蛋白用于人内脏利什曼病诊断的 ELISA 和免疫层析试验性能的改善。
J Immunol Res. 2021 Apr 28;2021:5568077. doi: 10.1155/2021/5568077. eCollection 2021.

本文引用的文献

1
Peptide-based vaccine successfully induces protective immunity against canine visceral leishmaniasis.基于肽的疫苗成功诱导出针对犬内脏利什曼病的保护性免疫。
NPJ Vaccines. 2019 Nov 29;4:49. doi: 10.1038/s41541-019-0144-2. eCollection 2019.
2
Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans.重组利什曼原虫真核延伸因子-1β蛋白:一种潜在的诊断抗原,可用于检测犬和人体的皮肤利什曼病和内脏利什曼病。
Microb Pathog. 2019 Dec;137:103783. doi: 10.1016/j.micpath.2019.103783. Epub 2019 Oct 7.
3
A rapid diagnostic test for human Visceral Leishmaniasis using novel antigens in a Laser Direct-Write Lateral Flow Device.利用激光直写横向流装置中的新型抗原快速诊断人体内脏利什曼病。
Emerg Microbes Infect. 2019;8(1):1178-1185. doi: 10.1080/22221751.2019.1635430.
4
Diagnostic evaluation of the amastin protein from Leishmania infantum in canine and human visceral leishmaniasis and immunogenicity in human cells derived from patients and healthy controls.利什曼原虫 amastin 蛋白在犬内脏利什曼病和人内脏利什曼病中的诊断评估及其在源自患者和健康对照者的人细胞中的免疫原性。
Diagn Microbiol Infect Dis. 2019 Oct;95(2):134-143. doi: 10.1016/j.diagmicrobio.2019.04.015. Epub 2019 May 6.
5
Screening diagnostic candidates from proteins for human visceral leishmaniasis using an immunoproteomics approach.利用免疫蛋白质组学方法从蛋白质中筛选人内脏利什曼病的诊断候选物。
Parasitology. 2019 Sep;146(11):1467-1476. doi: 10.1017/S0031182019000714. Epub 2019 Jun 13.
6
β-Tubulin Identified by Reverse Engineering Technology through Phage Display Applied as Theranostic Marker for Human Visceral Leishmaniasis.通过噬菌体展示反向工程技术鉴定的β-微管蛋白可用作人类内脏利什曼病的治疗诊断标志物。
Int J Mol Sci. 2019 Apr 12;20(8):1812. doi: 10.3390/ijms20081812.
7
Leishmania infantum recombinant kinesin degenerated derived repeat (rKDDR): A novel potential antigen for serodiagnosis of visceral leishmaniasis.婴儿利什曼原虫重组驱动蛋白退行性衍生重复序列(rKDDR):一种用于内脏利什曼病血清学诊断的新型潜在抗原。
PLoS One. 2019 Jan 31;14(1):e0211719. doi: 10.1371/journal.pone.0211719. eCollection 2019.
8
Visceral leishmaniasis and HIV coinfection: current perspectives.内脏利什曼病与艾滋病病毒合并感染:当前观点
HIV AIDS (Auckl). 2018 Oct 15;10:193-201. doi: 10.2147/HIV.S143929. eCollection 2018.
9
Diagnostic application of recombinant Leishmania proteins and evaluation of their in vitro immunogenicity after stimulation of immune cells collected from tegumentary leishmaniasis patients and healthy individuals.重组利什曼原虫蛋白的诊断应用及其在刺激皮肤利什曼病患者和健康个体采集的免疫细胞后的体外免疫原性评价。
Cell Immunol. 2018 Dec;334:61-69. doi: 10.1016/j.cellimm.2018.09.006. Epub 2018 Sep 28.
10
A Leishmania-specific gene upregulated at the amastigote stage is crucial for parasite survival.一种在无鞭毛体阶段上调的利什曼原虫特异性基因对寄生虫的存活至关重要。
Parasitol Res. 2018 Oct;117(10):3215-3228. doi: 10.1007/s00436-018-6020-6. Epub 2018 Aug 14.